Plain-English translation of NCT06633159 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is studying a minimally invasive procedure using the MitraClip G4 device to repair a leaky mitral valve in patients with heart failure. The device is a small clip that is inserted through a catheter (a thin tube) and gently clips together the edges of the valve leaflets to reduce the backward flow of blood. This treatment is designed for patients who are too sick or frail to have traditional open-heart surgery.
Many patients with a severely leaky heart valve cannot safely have traditional open-heart surgery because of age, other illnesses, or overall frailty. This trial exists to confirm that the clip device is safe and effective for these high-risk patients in Russia, and to gather real-world evidence about how well this treatment works and improves patients' quality of life.
You likely qualify if…
You likely don't qualify if…
The trial has two parts: some participants will be newly enrolled and monitored going forward (prospective group), while others have already had the procedure and their medical records will be reviewed (retrospective group). For new participants, you would undergo the MitraClip G4 procedure and then have follow-up visits and medical assessments to monitor your health, heart function, and any side effects. The study will track your outcomes and compare your health before and after the procedure.
AI-generated summary from trial data · Aug 12, 2026 · Not medical advice
Russia